Literature DB >> 10567398

The Ets factors PU.1 and Spi-B regulate the transcription in vivo of P2Y10, a lymphoid restricted heptahelical receptor.

S Rao1, L A Garrett-Sinha, J Yoon, M C Simon.   

Abstract

To investigate the in vivo functions of PU.1 and Spi-B, two highly related Ets transcription factors, we previously generated PU. 1(+/+)Spi-B(-/-) and PU.1(+/-)Spi-B(-/-) mice and demonstrated a significant decrease in B-cell receptor (BCR) signaling in mutants. Major components of BCR signaling appear to be expressed at normal levels in these mice, implying that PU.1 and Spi-B cooperate in the transcription of additional target genes important for antigen receptor signaling. We used subtractive hybridization to identify novel in vivo PU.1/Spi-B target genes and determined that the expression of a heptahelical receptor, P2Y10, is dramatically reduced in PU.1(+/-)Spi-B(-/-) B-cells. Further analysis shows that P2Y10 expression is restricted to lymphoid cells and parallels that of Spi-B in B-lymphocytes. Lastly, the P2Y10 promoter contains a PU. 1/Spi-B binding site functionally required for efficient transcription in B-cells. Thus, P2Y10 is likely to be a direct in vivo transcriptional target for PU.1 and Spi-B and provides a unique model to explore transcriptional regulation by this Ets factor subfamily. Furthermore, P2Y10 suggests an intriguing connection between heterotrimeric G-proteins and BCR signaling.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10567398     DOI: 10.1074/jbc.274.48.34245

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  16 in total

Review 1.  Subtractive hybridization--genetic takeaways and the search for meaning.

Authors:  R J Byers; J A Hoyland; J Dixon; A J Freemont
Journal:  Int J Exp Pathol       Date:  2000-12       Impact factor: 1.925

2.  50 million years of chordate evolution: seeking the origins of adaptive immunity.

Authors:  D J Laird; A W De Tomaso; M D Cooper; I L Weissman
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-20       Impact factor: 11.205

Review 3.  International Union of Pharmacology LVIII: update on the P2Y G protein-coupled nucleotide receptors: from molecular mechanisms and pathophysiology to therapy.

Authors:  Maria P Abbracchio; Geoffrey Burnstock; Jean-Marie Boeynaems; Eric A Barnard; José L Boyer; Charles Kennedy; Gillian E Knight; Marta Fumagalli; Christian Gachet; Kenneth A Jacobson; Gary A Weisman
Journal:  Pharmacol Rev       Date:  2006-09       Impact factor: 25.468

4.  Transgenic expression of Spi-C impairs B-cell development and function by affecting genes associated with BCR signaling.

Authors:  Xiang Zhu; Brock L Schweitzer; Eric J Romer; Courtney E W Sulentic; Rodney P DeKoter
Journal:  Eur J Immunol       Date:  2008-09       Impact factor: 5.532

5.  Spi-B inhibits human plasma cell differentiation by repressing BLIMP1 and XBP-1 expression.

Authors:  Heike Schmidlin; Sean A Diehl; Maho Nagasawa; Ferenc A Scheeren; Remko Schotte; Christel H Uittenbogaart; Hergen Spits; Bianca Blom
Journal:  Blood       Date:  2008-06-13       Impact factor: 22.113

Review 6.  Lysophospholipid receptor nomenclature review: IUPHAR Review 8.

Authors:  Yasuyuki Kihara; Michael Maceyka; Sarah Spiegel; Jerold Chun
Journal:  Br J Pharmacol       Date:  2014-07-12       Impact factor: 8.739

7.  Spi-B can functionally replace PU.1 in myeloid but not lymphoid development.

Authors:  Richard Dahl; Diana L Ramirez-Bergeron; Sridhar Rao; M Celeste Simon
Journal:  EMBO J       Date:  2002-05-01       Impact factor: 11.598

8.  Anatomical profiling of G protein-coupled receptor expression.

Authors:  Jean B Regard; Isaac T Sato; Shaun R Coughlin
Journal:  Cell       Date:  2008-10-31       Impact factor: 41.582

Review 9.  Aiming drug discovery at lysophosphatidic acid targets.

Authors:  Gabor Tigyi
Journal:  Br J Pharmacol       Date:  2010-09       Impact factor: 8.739

Review 10.  Novel lysophosphoplipid receptors: their structure and function.

Authors:  Kumiko Makide; Akiharu Uwamizu; Yuji Shinjo; Jun Ishiguro; Michiyo Okutani; Asuka Inoue; Junken Aoki
Journal:  J Lipid Res       Date:  2014-06-02       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.